In-Depth Mass Spectrometry Study of Vanadium(IV) Complexes with Model Peptides

Area of Science:

• Bioinorganic Chemistry
• Medicinal Chemistry
• Analytical Chemistry

Background:

• Understanding vanadium speciation in biological systems is crucial for metallodrug development.
• Oxidovanadium(IV) compounds show promise for antidiabetic and anticancer applications.
• Investigating interactions with biomolecules like peptides is key to elucidating mechanisms of action.

Purpose of the Study:

• To investigate the interaction of model peptides (angiotensin I and II) with oxidovanadium(IV) complexes.
• To identify vanadium binding sites on peptides using advanced analytical techniques.
• To provide insights for the development of novel vanadium-based metallodrugs.

Main Methods:

• Electrospray ionization tandem mass spectrometry (ESI-MS/MS) was the primary technique.
• Electron paramagnetic resonance (EPR) spectroscopy complemented the mass spectrometry data.
• Density functional theory (DFT) calculations were employed for theoretical analysis.

Main Results:

• Vanadium-peptide bonds remained intact after higher energy collisional dissociation (HCD) fragmentation.
• Angiotensin I showed bidentate coordination via two histidine residues.
• Angiotensin II exhibited monodentate coordination, with potential for further complexation.

Conclusions:

• ESI-MS/MS is a powerful tool for studying vanadium-peptide interactions and identifying binding sites.
• Different peptide sequences lead to distinct vanadium coordination behaviors.
• This research advances the understanding of vanadium metallodrugs and their interactions with biological targets.